Within 72 hours of FDA’s publication of the re-draft of the NDI Guidance, which could occur at any time between now and the end of the year, NPA will hold a Web conference highlighting the most important and pressing aspects of the guidance and its regulatory and scientific impact. Featured speakers include: Dr. Daniel Fabricant, Kevin Bell, Dr. Corey Hilmas, Ashish Talati (Amin Talati & Upadhye, LLC) and Dr. Cara Welch (FDA).
Date of webinar will be determined upon the release of the draft guidance.
*This webinar is not included in the webinar bundle.
